How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead? Press Coverage How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead? Discover how advances in personalized medicine are reshaping patient care, and why biosimulation will become…CertaraJanuary 31, 2025
How to Validate Your Clinical Data Using FDA Validation Rules Blog How to Validate Your Clinical Data Using FDA Validation Rules January 30, 2025 For clinical data managers, understanding clinical data validation and applying FDA validation…CertaraJanuary 30, 2025
Phoenix Hosted: Cloud-Based PK/PD Software for Smarter, Faster Research Webinar Phoenix Hosted: Cloud-Based PK/PD Software for Smarter, Faster Research CertaraJanuary 30, 2025
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences Press Release Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences January 29, 2025 Radnor, Pa. — January 29th, 2025 — Certara, Inc. (Nasdaq: CERT), a global…CertaraJanuary 29, 2025
Transforming Perspectives: 25 Years of PBPK Modeling in Drug-Drug Interactions On-Demand Webinar Transforming Perspectives: 25 Years of PBPK Modeling in Drug-Drug Interactions Vice President and Head of Global PK/PD and Pharmacometrics at Eli Lilly and Company Dr.…CertaraJanuary 29, 2025
The Benefits of Real-Time Nonclinical Safety Data Analysis White Paper The Benefits of Real-Time Nonclinical Safety Data Analysis Learn how SEND Explorer software helps nonclinical drug developers streamline performing real-time toxicology assessments of…CertaraJanuary 27, 2025
Understanding Variability in CAR-T Cell Therapy Kinetics Publication Understanding Variability in CAR-T Cell Therapy Kinetics Axicabtagene ciloleucel (axi-cel), a CAR-T cell therapy for relapsed and refractory non-Hodgkin’s lymphoma (NHL), demonstrates…CertaraJanuary 23, 2025
Certara Awarded European Medicines Agency Project to Assess Real-World Data Landscape for CAR-T Cell Therapies Announcement Certara Awarded European Medicines Agency Project to Assess Real-World Data Landscape for CAR-T Cell Therapies January 22, 2025 Radnor, PA – January 22, 2025 – Certara, Inc. (Nasdaq: CERT), a…CertaraJanuary 22, 2025
Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses Publication Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses This Frontiers in Pharmacology article investigates how using different time-averaged exposure metrics, specifically the time-averaged…CertaraJanuary 21, 2025
Model-Informed Drug Development: Current Landscape and Future Directions Live Events Model-Informed Drug Development: Current Landscape and Future Directions Date: Tuesday, February 25, 2025Time: 5:30 - 8:00pmVenue: CIC Cambridge - One Broadway, Cambridge, MA…CertaraJanuary 17, 2025